MDTMedtronic
Is it growing?
Neither accelerating nor breaking down: nothing decisive, though earnings up +12% year on year.
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +4% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.
Trailing-twelve-month operating margin, 18.1% now against 17.9% a year earlier.
All from SEC EDGAR, as of Jul 31, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is MDT growing?
Medtronic has grown revenue 6.0% a year over three years and 3.5% a year over five, with earnings per share compounding at 15%.
Revenue growth, 3-year annual rate · Medical Devices median +12% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +3.5%
Revenue growth, 5-year rate · +6.0% over three · growth has picked up over the last three years
- Earnings per share, 3-year rate
- +15%
Earnings per share, 3-year rate · revenue +6.0% · earnings outgrew revenue: margins or the share count worked for shareholders
- Years of annual history on file
- 14
Years of annual history on file · FY2013 to FY2026, as filed
Details›
- Revenue FY2022
- $31.7B
- Revenue FY2023
- $31.2B
- Revenue FY2024
- $32.4B
- Revenue FY2025
- $33.5B
- Revenue FY2026
- $36.4B
Annual income statements as filed with the SEC.
Medical Devices
The closest names by size in the same industry